Procter & Gamble Hygiene and Health Care LtdNSE: PGHH
Open the Procter & Gamble Hygiene and Health Care Ltd page
Follow Procter & Gamble Hygiene and Health Care LtdFree account. Get a note when Procter & Gamble Hygiene and Health Care Ltd files.
Q1 FY27 results analysis · July 29, 2026

PGHH Q1 FY27 Results Analysis: PAT Plunges 34%, Margin Collapses 933 bps

−34.2%PAT year on year, Rs. 126.27 Cr
Cofacto ResearchPublished July 29, 20262 min read
Quick summary

Procter & Gamble Hygiene and Health Care Ltd reported Q1 FY27 numbers with revenue of Rs. 891.46 Cr (-4.86% YoY) and PAT growth of -34.25% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 29, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 891.46 Cr (-4.86% YoY)
PAT (Q1)Rs. 126.27 Cr (-34.25% YoY)
EBITDA margin19.08% (-933 bps YoY)
EPS (Q1)Rs. 38.90 (-34.26% YoY)
Market capRs. 27,877.39 Cr
CMPRs. 8,593.00

Quarter Snapshot

PGHH reported a weak Q1 with revenue declining 4.86% YoY and EBITDA margin collapsing 933 bps to 19.08% due to severe commodity inflation. PAT fell 34% YoY, contradicting management's qualitative guidance of double-digit earnings growth. No near-term catalysts are evident, and the competitive position appears weakened.

Key Investment Insights

Key Positives

  • Other expenses as a % of revenue remained stable at 22.82% vs 22.69% a year ago
  • Effective tax rate improved to 25.56% from 27.44% a year ago
  • No exceptional items or one-time charges in the quarter

Risk Factors

  • Revenue declined 4.86% YoY to Rs.891.46 Cr, a weak start to FY27
  • EBITDA margin collapsed 933 bps YoY to 19.08% due to surging material costs
  • PAT declined 34.25% YoY to Rs.126.27 Cr, the steepest drop in recent quarters
  • Gross material cost rose 12.7% YoY despite revenue decline, driven by commodity inflation
  • Employee costs rose 12.4% YoY, adding to cost pressure
  • Management's stated goal of 'sustaining double-digit earnings growth' appears off-track with a 34% PAT decline

Ask about this

Ask Cofacto a question about this result. Answers cite filings and company data.

Companies on this page

Related

Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.